These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 10343630)

  • 1. Diagnosis of cystic fibrosis related diabetes: a selective approach in performing the oral glucose tolerance test based on a combination of clinical and biochemical criteria.
    Yung B; Kemp M; Hooper J; Hodson ME
    Thorax; 1999 Jan; 54(1):40-3. PubMed ID: 10343630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystic Fibrosis-Related Diabetes Screening in Adults: A Gap Analysis and Evaluation of Accuracy of Glycated Hemoglobin Levels.
    Gilmour JA; Sykes J; Etchells E; Tullis E
    Can J Diabetes; 2019 Feb; 43(1):13-18. PubMed ID: 30173928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HbA1c as a screening tool for cystic fibrosis related diabetes.
    Burgess JC; Bridges N; Banya W; Gyi KM; Hodson ME; Bilton D; Simmonds NJ
    J Cyst Fibros; 2016 Mar; 15(2):251-7. PubMed ID: 25869326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of hemoglobin A1c to identify dysglycemia in cystic fibrosis.
    Darukhanavala A; Van Dessel F; Ho J; Hansen M; Kremer T; Alfego D
    PLoS One; 2021; 16(4):e0250036. PubMed ID: 33882078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel time-saving OGTT sparing HbA1c-HOMA2 based algorithm for the diagnosis of cystic fibrosis-related diabetes.
    Lurquin F; Gohy S; Hermans MP; Preumont V
    Diabetes Res Clin Pract; 2024 Feb; 208():111124. PubMed ID: 38309533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: is the oral glucose tolerance test still the standard?
    Mainguy C; Bellon G; Delaup V; Ginoux T; Kassai-Koupai B; Mazur S; Rabilloud M; Remontet L; Reix P
    J Pediatr Endocrinol Metab; 2017 Jan; 30(1):27-35. PubMed ID: 27977404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycated hemoglobin cannot yet be proposed as a screening tool for cystic fibrosis related diabetes.
    Boudreau V; Coriati A; Desjardins K; Rabasa-Lhoret R
    J Cyst Fibros; 2016 Mar; 15(2):258-60. PubMed ID: 26905501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycated Hemoglobin as a First-line Screening Test for Cystic Fibrosis‒Related Diabetes and Impaired Glucose Tolerance in Children With Cystic Fibrosis: A Validation Study.
    Racine F; Shohoudi A; Boudreau V; Nguyen CQT; Denis MH; Desjardins K; Reynaud Q; Rabasa-Lhoret R; Mailhot G
    Can J Diabetes; 2021 Dec; 45(8):768-774. PubMed ID: 33926819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New criteria for impaired fasting glucose and screening for diabetes in cystic fibrosis.
    Mueller-Brandes C; Holl RW; Nastoll M; Ballmann M
    Eur Respir J; 2005 Apr; 25(4):715-7. PubMed ID: 15802348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test.
    Schmid K; Fink K; Holl RW; Hebestreit H; Ballmann M
    J Cyst Fibros; 2014 Jan; 13(1):80-5. PubMed ID: 23809507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of glucose area under the curve from the oral glucose tolerance test as a screening tool for cystic fibrosis-related diabetes.
    Gileles-Hillel A; Soesman LH; Miari S; Breuer O; Tsabari R; Elyashar-Earon H; Armoni S; Sprikkelman AB; Reiter J; Zangen D; Lavi E; Kerem E; Cohen-Cymberknoh M
    Pediatr Pulmonol; 2022 Nov; 57(11):2774-2780. PubMed ID: 35999051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.
    Scully KJ; Brenner L; Martin K; Ruazol M; Sawicki GS; Uluer A; Neuringer I; Yonker LM; Sicilian L; Putman MS
    Front Endocrinol (Lausanne); 2024; 15():1293709. PubMed ID: 38379863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral glucose tolerance test and continuous glucose monitoring to assess diabetes development in cystic fibrosis patients.
    Clemente León M; Bilbao Gassó L; Moreno-Galdó A; Campos Martorrell A; Gartner Tizzano S; Yeste Fernández D; Carrascosa Lezcano A
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Jan; 65(1):45-51. PubMed ID: 29137964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
    Khammar A; Stremler N; Dubus JC; Gross G; Sarles J; Reynaud R
    Arch Pediatr; 2009 Dec; 16(12):1540-6. PubMed ID: 19854630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Screening and management of glucose metabolism disorders in cystic fibrosis patients. Practices survey in 4 French reference centers].
    Haesebaert J; Bourdy S; Perceval M; Chabloz C; Nove-Josserand R; Reix P; Llerena C; Wion N; Touzet S
    Arch Pediatr; 2009 Nov; 16(11):1435-42. PubMed ID: 19811898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose >200 mg/dL during Continuous Glucose Monitoring Identifies Adult Patients at Risk for Development of Cystic Fibrosis Related Diabetes.
    Taylor-Cousar JL; Janssen JS; Wilson A; Clair CG; Pickard KM; Jones MC; Brayshaw SJ; Chacon CS; Barboa CM; Sontag MK; Accurso FJ; Nichols DP; Saavedra MT; Nick JA
    J Diabetes Res; 2016; 2016():1527932. PubMed ID: 27999822
    [No Abstract]   [Full Text] [Related]  

  • 17. The Relationship Between Continuous Glucose Monitoring and OGTT in Youth and Young Adults With Cystic Fibrosis.
    Chan CL; Pyle L; Vigers T; Zeitler PS; Nadeau KJ
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e548-e560. PubMed ID: 34537845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for Cystic Fibrosis-Related Diabetes: Matching Pathophysiology and Addressing Current Challenges.
    Boudreau V; Reynaud Q; Dubois CL; Coriati A; Desjardins K; Durieu I; Rabasa-Lhoret R
    Can J Diabetes; 2016 Oct; 40(5):466-470. PubMed ID: 27737759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes in cystic fibrosis: multicenter screening results based on current guidelines.
    Scheuing N; Holl RW; Dockter G; Fink K; Junge S; Naehrlich L; Smaczny C; Staab D; Thalhammer G; van Koningsbruggen-Rietschel S; Ballmann M
    PLoS One; 2013; 8(12):e81545. PubMed ID: 24324701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystic fibrosis related diabetes mellitus - diagnostic and management challenges.
    Lek N; Acerini CL
    Curr Diabetes Rev; 2010 Jan; 6(1):9-16. PubMed ID: 20034372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.